Cargando…
The influence of 17q21.31 and APOE genetic ancestry on neurodegenerative disease risk
Advances in genomic research over the last two decades have greatly enhanced our knowledge concerning the genetic landscape and pathophysiological processes involved in multiple neurodegenerative diseases. However, current insights arise almost exclusively from studies on individuals of European anc...
Autores principales: | Harerimana, Nadia V., Goate, Alison M., Bowles, Kathryn R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632173/ https://www.ncbi.nlm.nih.gov/pubmed/36337698 http://dx.doi.org/10.3389/fnagi.2022.1021918 |
Ejemplares similares
-
Structural Diversity and African Origin of the 17q21.31 Inversion Polymorphism
por: Steinberg, Karyn Meltz, et al.
Publicado: (2012) -
An Epigenetic Signature in Peripheral Blood Associated with the Haplotype on 17q21.31, a Risk Factor for Neurodegenerative Tauopathy
por: Li, Yun, et al.
Publicado: (2014) -
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
por: Permuth-Wey, Jennifer, et al.
Publicado: (2013) -
17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
por: Bowles, Kathryn R., et al.
Publicado: (2022) -
Menkes disease complicated by concurrent Koolen‐de Vries syndrome (17q21.31 deletion)
por: Woodfin, Taylor, et al.
Publicado: (2019)